According to Futu News on August 8, Hong Kong stocks opened low today. As of press time, the Hang Seng Index fell 0.86%, the Hang Seng Technology Index fell 1.87%, and the State-owned Enterprises Index fell 1.17%.
Star technology stocks generally fell.BABA fell by more than 3%, JD.com by more than 2%, Tencent and Meituan by more than 1%.
Most coal stocks are up.Yanzhou Mining Energy rose more than 2 per cent and China Shenhua Energy rose more than 1 per cent.
Most of the inner housing stocks roseThe development of the new town rose by more than 3%, and Country Garden Holdings by more than 1%.
Auto stocks fell.NIO Inc. fell nearly 4%, Geely and XPeng Inc. fell more than 2%.
Individual stocks$BABA-SW (09988.HK) $It fell by more than 3%, with a turnover of HK $1.339 billion. Macquarie reiterated the company's "outperform" rating, raising the adjusted diluted earnings per share forecast for fiscal year 2023 to 24 by 1% to 2%, with the target price rising from HK $145 to HK $148.
$INNOVENT BIO (01801.HK) $It rose by more than 3%, and by more than 15% for three consecutive trading days. On the news side, the company reached a multi-project strategic cooperation and licensing agreement with Sanofi Group, and will receive a 600 million euro premium investment; and its bispecific antibody injection completed the first subject administration in a phase I clinical trial for the treatment of diabetic macular edema (DME).
$Macro Optical Semiconductor (06908.HK) $The resumption of trading rose by more than 22%, with a turnover of HK $27.8 million. The company announced that 30 million shares had been placed at a price of HK $3.20, with a total proceeds of HK $96 million.
$minimally invasive medical treatment (00853.HK) $It fell nearly 7%, with a turnover of HK $90.51 million. On the news side, the company announced that it expects a loss of about $193 million to $203 million during the period attributable to equity shareholders in the first half of 2022, compared with a loss of about $90.3 million in the same period last year.
Edit / Jeffrey